ATE349702T1 - Nachweis und quantifizierung von cripto-1 - Google Patents

Nachweis und quantifizierung von cripto-1

Info

Publication number
ATE349702T1
ATE349702T1 AT02703238T AT02703238T ATE349702T1 AT E349702 T1 ATE349702 T1 AT E349702T1 AT 02703238 T AT02703238 T AT 02703238T AT 02703238 T AT02703238 T AT 02703238T AT E349702 T1 ATE349702 T1 AT E349702T1
Authority
AT
Austria
Prior art keywords
cripto
quantification
detection
present
serum
Prior art date
Application number
AT02703238T
Other languages
English (en)
Inventor
Caterina Bianco
David Salomon
Original Assignee
Us Gov Health & Human Serv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Us Gov Health & Human Serv filed Critical Us Gov Health & Human Serv
Application granted granted Critical
Publication of ATE349702T1 publication Critical patent/ATE349702T1/de

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6872—Intracellular protein regulatory factors and their receptors, e.g. including ion channels
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6854—Immunoglobulins
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/475—Assays involving growth factors
    • G01N2333/485—Epidermal growth factor [EGF] (urogastrone)

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Cell Biology (AREA)
  • Medicinal Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Biotechnology (AREA)
  • Food Science & Technology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Pathology (AREA)
  • Peptides Or Proteins (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Sub-Exchange Stations And Push- Button Telephones (AREA)
  • Glass Compositions (AREA)
  • Testing Of Coins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
AT02703238T 2001-01-26 2002-01-23 Nachweis und quantifizierung von cripto-1 ATE349702T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US26464301P 2001-01-26 2001-01-26

Publications (1)

Publication Number Publication Date
ATE349702T1 true ATE349702T1 (de) 2007-01-15

Family

ID=23006978

Family Applications (1)

Application Number Title Priority Date Filing Date
AT02703238T ATE349702T1 (de) 2001-01-26 2002-01-23 Nachweis und quantifizierung von cripto-1

Country Status (9)

Country Link
US (1) US7078176B2 (de)
EP (1) EP1370869B1 (de)
JP (1) JP3821779B2 (de)
AT (1) ATE349702T1 (de)
AU (1) AU2002236871B2 (de)
CA (1) CA2434694C (de)
DE (1) DE60217079T2 (de)
ES (1) ES2278899T3 (de)
WO (1) WO2002059620A2 (de)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20020010928A1 (en) * 2000-04-24 2002-01-24 Ranjit Sahota Method and system for integrating internet advertising with television commercials
EE200300528A (et) 2001-04-26 2004-08-16 Biogen, Inc. Cripto valku blokeerivad antikehad ja nende kasutamine
US7582299B2 (en) 2001-04-26 2009-09-01 Biogen Idec Ma Inc. Cripto-specific antibodies
WO2004037990A2 (en) * 2002-10-23 2004-05-06 Exelixis, Inc. MBMs AS MODIFIERS OF BRANCHING MORPHOGENESIS AND METHODS OF USE
JP2006515745A (ja) * 2002-10-23 2006-06-08 エクセリクシス， インク． 分枝形態形成のモディファイヤーとしてのｍａｐ２ｋ６及び使用方法
WO2005033341A2 (en) * 2003-10-03 2005-04-14 Government Of The United States Of America, Represented By The Secretary, Department Of Health And Human Services Use of cripto-1 as a biomarker for neurodegenerative disease and method of inhibiting progression thereof
CA2593212A1 (en) 2005-01-05 2006-07-13 Biogen Idec Ma Inc. Cripto binding molecules
WO2009131852A1 (en) * 2008-04-21 2009-10-29 Merck & Co., Inc. Pancreatic beta-cell mass biomarker
CN102272157B (zh) * 2008-11-07 2015-11-25 研究发展基金会 用于抑制cripto/grp78复合物形成和信号的组合物和方法

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US579616A (en) * 1897-03-30 Rod-packing for air-brakes
US5256643A (en) * 1990-05-29 1993-10-26 The Government Of The United States Human cripto protein
US5264557A (en) * 1991-08-23 1993-11-23 The United States Of America As Represented By The Department Of Health And Human Services Polypeptide of a human cripto-related gene, CR-3
US5981215A (en) * 1995-06-06 1999-11-09 Human Genome Sciences, Inc. Human criptin growth factor
US5968839A (en) * 1996-05-13 1999-10-19 Metrika, Inc. Method and device producing a predetermined distribution of detectable change in assays
US6777198B2 (en) * 2000-10-11 2004-08-17 Pharmacia Diagnostics Ab Assay method and kit therefor

Also Published As

Publication number Publication date
WO2002059620A3 (en) 2003-03-27
AU2002236871C1 (en) 2002-08-06
EP1370869B1 (de) 2006-12-27
JP3821779B2 (ja) 2006-09-13
DE60217079T2 (de) 2007-10-25
CA2434694C (en) 2012-09-18
US7078176B2 (en) 2006-07-18
JP2005504262A (ja) 2005-02-10
EP1370869A2 (de) 2003-12-17
ES2278899T3 (es) 2007-08-16
CA2434694A1 (en) 2002-08-01
US20040077025A1 (en) 2004-04-22
WO2002059620A2 (en) 2002-08-01
DE60217079D1 (de) 2007-02-08
AU2002236871B2 (en) 2006-09-28

Similar Documents

Publication Publication Date Title
WO2003000853A3 (en) Protein aggregation assays and uses thereof
WO2005012574A3 (en) Biological bar-code
MX340077B (es) Sistemas de fluidos de punto de cuidado y usos de los mismos.
ATE540319T1 (de) Verfahren für die bestimmung von fk506
MA30153B1 (fr) Anticorps anti-ox40l et methodes correspondantes
WO2003064993A3 (en) Methods and materials for detecting genetic material
NO20041160L (no) Bio-avlesningsplattform for pavisning og kvantitering av biologiske molekyler
ATE256131T1 (de) Calanolide zur hemmung von btk
AU2002259117A1 (en) Systems and methods for detection of analytes in biological fluids
ES2177316T3 (es) Anticuerpos humanos antifacotores ix/ixa.
ATE349702T1 (de) Nachweis und quantifizierung von cripto-1
WO2009082445A3 (en) Novel devices for the detection of the presence and/or activity of proteases in biological samples
WO2004016160A3 (en) Redox polymer nanoparticles
BR0314155A (pt) Métodos para diagnosticar câncer cervical
WO2003084384A3 (en) Diagnosis of flavivirus infection
BR0014626A (pt) Análise de leptina
WO2003027251A3 (en) Novel molecules of the pyrin domain protein family and uses thereof
EP1503321A3 (de) Automatisierte Proteinkonstruktion für Proteinbibliotheken
WO2005044244A3 (de) Verwendung von mrp4-inhibitoren zur behandlung und/oder prophylaxe kardiovaskulärer erkrankungen
ATE557034T1 (de) Identifikation von epitopen und erniedrigung der allergenität von nahrungsmittelproteinen
AU2002340881A1 (en) Concentration of protein and/or peptides samples
DE60224663D1 (de) Verwendung einer miniaturvorrichtung zur trennung und isolierung biologischer objekte und trennungsverfahren
FR2841156B1 (fr) Nouvelles particules magnetiques fluorescentes,ainsi que les conjugues de telles particules et les compositions diagnostiques , therapeutiques ou prophylactiques les contenant
DE69918128D1 (de) Mutierte gewebefaktor-inhibitor (tfpi), dna sequenz davon und verwendung zur erkennung von thrombotischen erkrankungen
ATE466076T1 (de) Gewebe transglutaminase

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties